Rating: Strong Buy
Danaher Financial Health
Profitability:6.42/10
❌ Danaher has worst Profitability than 55.56% of the companies on the Medical Diagnostics & Research industry
Net Margin: 16.84%
✅ Danaher has better Net Margin than 77.78% of the companies on the Medical Diagnostics & Research industry
ROE (Return on Equity): 2.59%
❌ Danaher has worst ROE (Return on Equity) than 50% of the companies on the Medical Diagnostics & Research industry
ROA (Return on Assets): 1.39%
❌ Danaher has worst ROA (Return on Assets) than 55.56% of the companies on the Medical Diagnostics & Research industry
Operating Efficiency:6.88/10
✅ Danaher has better Operating Efficiency than 70% of the companies on the Medical Diagnostics & Research industry
Operating Margin: 16.72%
✅ Danaher has better Operating Margin than 70% of the companies on the Medical Diagnostics & Research industry
Liquidity:5.78/10
❌ Danaher has worst Liquidity than 60% of the companies on the Medical Diagnostics & Research industry
Quick Ratio: 1.32
❌ Danaher has worst Quick Ratio than 50% of the companies on the Medical Diagnostics & Research industry
Operating Cash Flow Ratio: 0.43
❌ Danaher has worst Operating Cash Flow Ratio than 60% of the companies on the Medical Diagnostics & Research industry
Solvency:6.82/10
✅ Danaher has better Solvency than 70% of the companies on the Medical Diagnostics & Research industry
Debt to Equity Ratio: 0.84
❌ Danaher has worst Debt to Equity Ratio than 60% of the companies on the Medical Diagnostics & Research industry
Interest Coverage Ratio: 0.43
❌ Danaher has worst Interest Coverage Ratio than 60% of the companies on the Medical Diagnostics & Research industry